Phase 2 study of veliparib plus FOLFIRI ± bevacizumab versus placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer.Vera Gorbunova,Thaddeus Beck,Ralf Hofheinz,Pilar Garcia-Alfonso,Marina Nechaeva,Antonio Cubillo Gracian,Laszlo Mangel,Elena Elez,Dustin A. Deming,Ramesh K. Ramanathan,Alison Torres,Danielle Marie Sullivan,Philip B. Komarnitsky,Jordan BerlinJournal of Clinical Oncology(2018)引用 30|浏览30暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要